Clinical Trial Update: Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy [Phase 1, Phase 2]

View source ↗

Summary

Pilot and feasibility phase 1/2 trial investigating 2'-fucosyllactose as a dietary supplement in inflammatory bowel disease patients on stable maintenance anti-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• 2'-fucosyllactose (2'-fucosyllactose)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Inflammatory Bowel Diseases, Crohn Disease | Phase 1, Phase 2 | Status: RECRUITING